↓ Skip to main content

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Overview of attention for article published in The Lancet, September 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#12 of 36,698)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Citations

dimensions_citation
223 Dimensions

Readers on

mendeley
820 Mendeley
Title
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Published in
The Lancet, September 2020
DOI 10.1016/s0140-6736(20)31866-3
Pubmed ID
Authors

Denis Y Logunov, Inna V Dolzhikova, Olga V Zubkova, Amir I Tukhvatulin, Dmitry V Shcheblyakov, Alina S Dzharullaeva, Daria M Grousova, Alina S Erokhova, Anna V Kovyrshina, Andrei G Botikov, Fatima M Izhaeva, Olga Popova, Tatiana A Ozharovskaya, Ilias B Esmagambetov, Irina A Favorskaya, Denis I Zrelkin, Daria V Voronina, Dmitry N Shcherbinin, Alexander S Semikhin, Yana V Simakova, Elizaveta A Tokarskaya, Nadezhda L Lubenets, Daria A Egorova, Maksim M Shmarov, Natalia A Nikitenko, Lola F Morozova, Elena A Smolyarchuk, Evgeny V Kryukov, Vladimir F Babira, Sergei V Borisevich, Boris S Naroditsky, Alexander L Gintsburg

Twitter Demographics

The data shown below were collected from the profiles of 12,649 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 820 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 820 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 185 23%
Researcher 117 14%
Student > Master 72 9%
Student > Ph. D. Student 66 8%
Other 59 7%
Other 157 19%
Unknown 164 20%
Readers by discipline Count As %
Medicine and Dentistry 254 31%
Biochemistry, Genetics and Molecular Biology 94 11%
Immunology and Microbiology 51 6%
Agricultural and Biological Sciences 43 5%
Pharmacology, Toxicology and Pharmaceutical Science 42 5%
Other 136 17%
Unknown 200 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 11161. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 May 2021.
All research outputs
#73
of 17,638,294 outputs
Outputs from The Lancet
#12
of 36,698 outputs
Outputs of similar age
#10
of 307,393 outputs
Outputs of similar age from The Lancet
#2
of 410 outputs
Altmetric has tracked 17,638,294 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 36,698 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 55.6. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 307,393 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 410 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.